DHEA supplementation: the claims in perspective.
暂无分享,去创建一个
[1] N. Martin,et al. Genetics of serum dehydroepiandrosterone sulfate and its relationship to insulin in a population-based cohort of twin subjects. , 2002, The Journal of clinical endocrinology and metabolism.
[2] Z. Sadowski,et al. Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. , 1989, Atherosclerosis.
[3] K. Barnhart,et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. , 2000, The Journal of clinical endocrinology and metabolism.
[4] B. Allolio,et al. DHEA treatment: myth or reality? , 2002, Trends in Endocrinology & Metabolism.
[5] H. Weisman,et al. Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury. , 1988, The Journal of clinical investigation.
[6] P. Minghetti,et al. Development of Patches for the Controlled Release of Dehydroepiandrosterone , 2001, Drug development and industrial pharmacy.
[7] Z. Liu,et al. Effects of sex hormones on apoptosis in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. , 2001, Chinese Medical Journal.
[8] S. Crawford,et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. , 2002, The Journal of clinical endocrinology and metabolism.
[9] T. Mune,et al. Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor gamma in adipocytes. , 2003, Endocrinology.
[10] E. Baulieu,et al. Dehydroepiandrosterone (DHEA): a fountain of youth? , 1996, The Journal of clinical endocrinology and metabolism.
[11] B. Bengtsson,et al. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. , 2002, The Journal of clinical endocrinology and metabolism.
[12] L. Garcia-Segura,et al. Dehydroepiandrosterone regulates insulin-like growth factor-1 system in adult rat hypothalamus , 2002, Endocrine.
[13] M. Garaulet,et al. Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables. , 2002, The journal of nutrition, health & aging.
[14] F. Salek,et al. The Influence of Hormones and Pharmaceutical Agents on DHEA and DHEA‐S Concentrations: A Review of Clinical Studies , 2002, Journal of clinical pharmacology.
[15] A. M. Linares,et al. Endogenous concentrations of DHEA and DHEA-S Decrease with remission of depression in older adults , 2001, Biological Psychiatry.
[16] C. Labrie,et al. High bioavailability of dehydroepiandrosterone administered percutaneously in the rat. , 1996, The Journal of endocrinology.
[17] W. Grizzle,et al. Aging alters zonation in the adrenal cortex of men. , 1997, The Journal of clinical endocrinology and metabolism.
[18] G. Hammond,et al. ADRENOCORTICAL FUNCTION IN PUBERTY Serum ACTH, Cortisol and Dehydroepiandrosterone in Girls and Boys , 1979, Acta paediatrica Scandinavica.
[19] C. Owen,et al. Review of estrone sulfatase and its inhibitors--an important new target against hormone dependent breast cancer. , 2002, Current medicinal chemistry.
[20] S. Wallenstein,et al. Relationship of endogenous levels of sex hormones to cognition and depression in frail, elderly women. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[21] D. Cucinotta,et al. Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women. , 2001, European journal of endocrinology.
[22] E. Engleman,et al. An open study of dehydroepiandrosterone in systemic lupus erythematosus. , 1994, Arthritis and rheumatism.
[23] H. Nakagama,et al. Chemoprevention of precursors to colon cancer by dehydroepiandrosterone (DHEA). , 2002, Life sciences.
[24] Dehydroepiandrosterone (DHEA) treatment of depression , 1997, Biological Psychiatry.
[25] Y. Arad,et al. Dehydroepiandrosterone Feeding Prevents Aortic Fatty Streak Formation and Cholesterol Accumulation in Cholesterol‐fed Rabbit , 1989, Arteriosclerosis.
[26] W. Mayo,et al. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging , 2001, Brain Research Reviews.
[27] N. Wong,et al. Effects of dehydroepiandrosterone on rat apolipoprotein AI gene expression in the human hepatoma cell line, HepG2. , 2002, Metabolism: clinical and experimental.
[28] M. Fassnacht,et al. Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. , 2001, The Journal of clinical endocrinology and metabolism.
[29] K. E. Schwartz,et al. Effects of Oral Prasterone (Dehydroepiandrosterone) on Single‐Dose Pharmacokinetics of Oral Prednisone and Cortisol Suppression in Normal Women , 2001, Journal of clinical pharmacology.
[30] R. Pommier,et al. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy. , 2001, Surgery.
[31] J. Nolla,et al. The association of dehydroepiandrosterone sulphate levels with bone mineral density in systemic lupus erythematosus. , 1997, Clinical and experimental rheumatology.
[32] N. Orentreich,et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. , 1984, The Journal of clinical endocrinology and metabolism.
[33] M. Genovese,et al. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus , 1999, Lupus.
[34] B. Allolio,et al. Dhea Replacement in Women with Adrenal Insufficiency—Pharmacokinetics, Bioconversion and Clinical Effects on Well-Being, Sexuality and Cognition , 2000, Endocrine research.
[35] F. Silvagno,et al. Synergistic effect of retinoic acid and dehydroepiandrosterone on differentiation of human neuroblastoma cells , 2002, FEBS letters.
[36] G. Gordon,et al. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[37] W. Scherbaum,et al. Differential gene expression profile of glucocorticoids, testosterone, and dehydroepiandrosterone in human cells. , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[38] S. Yen,et al. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. , 1994, The Journal of clinical endocrinology and metabolism.
[39] J. Souberbielle,et al. DHEA in bone and joint diseases. , 2001, Joint, bone, spine : revue du rhumatisme.
[40] T. Pollmächer,et al. The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. , 2002, The Journal of endocrinology.
[41] S. Norton,et al. Administration of dehydroepiandrosterone sulfate retards onset but not progression of autoimmune disease in NZB/W mice. , 1997, Autoimmunity.
[42] E. Baulieu,et al. AN ADRENAL-SECRETED "ANDROGEN": DEHYDROISOANDROSTERONE SULFATE. ITS METABOLISM AND A TENTATIVE GENERALIZATION ON THE METABOLISM OF OTHER STEROID CONJUGATES IN MAN. , 1965, Recent progress in hormone research.
[43] E. Barrett-Connor,et al. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. , 1986, The New England journal of medicine.
[44] E. Baulieu,et al. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[45] S. Emans,et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. , 2002, The Journal of clinical endocrinology and metabolism.
[46] C. Kirschbaum,et al. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. , 1997, The Journal of clinical endocrinology and metabolism.
[47] C. Labrie,et al. Intracrinology and The Skin , 2001, Hormone Research in Paediatrics.
[48] E. Engleman,et al. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. , 1998, The Journal of rheumatology.
[49] B. Yang,et al. Exogenous dehydroepiandrosterone modified the expression of T helper-related cytokines in NZB/NZW F1 mice. , 1998, Immunological investigations.
[50] A. Honda,et al. Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines , 2003, Steroids.
[51] G. Ceschel,et al. Skin permeation study of dehydroepiandrosterone (DHEA) compared with its alpha-cyclodextrin complex form. , 2002, Journal of pharmaceutical sciences.
[52] J. Herbert,et al. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone‐induced suppression , 2002, The European journal of neuroscience.
[53] P. Seed,et al. Low circulating estradiol and adrenal androgens concentrations in men on glucocorticoids: a potential contributory factor in steroid-induced osteoporosis. , 2002, Metabolism: clinical and experimental.
[54] R. Takayanagi,et al. Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts , 2002, Mechanisms of Ageing and Development.
[55] Felicia A Huppert,et al. Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation , 2001, Psychoneuroendocrinology.
[56] J. Deslypere,et al. Fat tissue: a steroid reservoir and site of steroid metabolism. , 1985, The Journal of clinical endocrinology and metabolism.
[57] M. Cascante,et al. Metabolic Control Analysis Aimed at the Ribose Synthesis Pathways of Tumor Cells: A New Strategy for Antitumor Drug Development , 2004, Molecular Biology Reports.
[58] M. Racchi,et al. Dehydroepiandrosterone and the relationship with aging and memory: a possible link with protein kinase C functional machinery , 2001, Brain Research Reviews.
[59] Abraham Weizman,et al. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. , 2003, Archives of general psychiatry.
[60] F. Labrie,et al. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. , 1997, The Journal of clinical endocrinology and metabolism.
[61] W. Arlt. Dehydroepiandrosterone and ageing. , 2004, Best practice & research. Clinical endocrinology & metabolism.
[62] F. Huppert,et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. , 2000, The Journal of clinical endocrinology and metabolism.
[63] O. Wolkowitz,et al. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men. , 2002, The Journal of clinical endocrinology and metabolism.
[64] E. Husebye,et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. , 2003, The Journal of clinical endocrinology and metabolism.
[65] K. Carlström,et al. Ovarian Ultrasound and Ovarian and Adrenal Hormones before and after Treatment for Hyperthyroidism , 2002, Gynecologic and Obstetric Investigation.
[66] G. Gordon,et al. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin. , 2001, Anticancer research.
[67] H. Furusawa,et al. Accumulation of 4- and 5-ene steroid sulfates in human breast cyst fluids , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[68] O. Wolkowitz,et al. Double-blind treatment of major depression with dehydroepiandrosterone. , 1999, The American journal of psychiatry.
[69] E. Mariani,et al. Dehydroepiandrosterone-sulfate serum levels and common age-related diseases: results from a cross-sectional Italian study of a general elderly population , 2002, Experimental Gerontology.
[70] T. Olsson,et al. Increased Levels of Adrenocortical and Gonadal Hormones in Mild to Moderate Alzheimer’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.
[71] J. Pepping. DHEA: dehydroepiandrosterone. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[72] S. Luo,et al. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. , 2002, Arthritis and rheumatism.
[73] E. Baulieu,et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[74] F. Huppert,et al. WITHDRAWN: Dehydroepiandrosterone (DHEA) supplementation for cognitive function. , 2007, The Cochrane database of systematic reviews.
[75] M. Catalano,et al. Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. , 2002, Endocrinology.
[76] C. Longcope. Dehydroepiandrosterone metabolism. , 1996, The Journal of endocrinology.
[77] J. Dunn,et al. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. , 1981, The Journal of clinical endocrinology and metabolism.
[78] J. Mckinlay,et al. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. , 2001, American journal of epidemiology.
[79] E. Barrett-Connor,et al. The Epidemiology of DHEAS and Cardiovascular Disease , 1995, Annals of the New York Academy of Sciences.
[80] C. Longcope,et al. Dehydroepiandrosterone metabolism in the female rhesus monkey: Oral versus intravenous administration , 1996, Steroids.
[81] R. Klein,et al. Sex Hormones and DHEA-SO4 in Relation to Ischemic Heart Disease Mortality in Diabetic subjects: The Wisconsin Epidemiologic Study of Diabetic Retinopathy , 1996, Diabetes Care.
[82] K. E. Schwartz,et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. , 2002, Arthritis and rheumatism.
[83] K. Esposito,et al. Cytokine pattern in postmenopause. , 2002, Maturitas.
[84] E. Engleman,et al. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. , 1995, Arthritis and rheumatism.
[85] A. Root,et al. Secretion of the adrenal androgen, dehydroepiandrosterone sulfate, during normal infancy, childhood, and adolescence, in sick infants, and in children with endocrinologic abnormalities. , 1977, The Journal of pediatrics.
[86] D. Pepin,et al. Conversion of dehydroepiandrosterone sulfate at physiological plasma concentration into estrogens in MCF-7 cells , 2002, Steroids.
[87] T. T. Have,et al. DHEA-S levels and depressive symptoms in a cohort of African American and Caucasian women in the late reproductive years , 2001, Biological Psychiatry.
[88] S. Bornstein,et al. Neuroimmunoregulation of Androgens in the Adrenal Gland and the Skin , 2000, Hormone Research in Paediatrics.
[89] J. Parasrampuria,et al. Quality control of dehydroepiandrosterone dietary supplement products. , 1998, JAMA.
[90] M. Hess,et al. Dehydroepiandrosterone Inhibits Human Platelet Aggregation in Vitro and in Vivo a , 1995, Annals of the New York Academy of Sciences.
[91] S. Andò,et al. The direct proliferative stimulus of dehydroepiandrosterone on MCF7 breast cancer cells is potentiated by overexpression of aromatase , 2001, Molecular and Cellular Endocrinology.